Getting your COVID-19 and flu vaccines on the same visit is safe, effective, and endorsed by every major health authority. Large studies involving tens of thousands of people have found that the side-effect profile of receiving both shots together closely matches what you would expect from either shot alone, and real-world data suggest the vaccines work just as well whether given simultaneously or weeks apart. The more interesting story is what happens beneath the surface when two vaccines meet your immune system at once, and why the research community is already working to put both into a single injection.
What the Safety Data Actually Shows
The biggest concern people have is that two vaccines at once means double the side effects. The data tell a more reassuring story. A large U.S. surveillance study tracked reactions in the week after vaccination among people who received both an mRNA COVID booster and an influenza shot simultaneously. People who got both were only slightly more likely to report a systemic reaction compared with people who got the COVID booster alone. For those who received a Pfizer booster with the flu shot, the increase was modest, and the pattern was similar for those receiving Moderna with the flu shot.1PubMed Central. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US The types of reactions were the usual suspects: arm soreness, fatigue, headache, and muscle aches. Nothing new appeared on the list.
Beyond everyday reactions, researchers have also looked at more serious adverse events. A target trial emulation study compared same-day COVID-plus-flu vaccination against flu vaccination alone and examined 46 individual adverse events. Across every category of outcomes studied, the risks were statistically similar between the two groups. Two individual events, syncope (briefly fainting) and tinnitus, showed borderline differences, but neither held up after the researchers accounted for the sheer number of comparisons being made.2PubMed. Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone In other words, the study found no meaningful safety signal from getting both vaccines on the same day.
Clinical trial data in younger age groups reinforces this picture. A multi-site trial that enrolled participants aged five and older found comparable reaction rates whether the vaccines were given simultaneously or about two weeks apart. All reported reactions were short-lived, and no participant in either group needed medical care for a vaccine reaction. The bottom line on safety is about as clear as it gets in medicine: co-administration does not introduce new risks beyond what each vaccine carries individually.
Do the Vaccines Work as Well When Given Together?
Safety is the easier question. Immunogenicity, meaning how strong an immune response the vaccines provoke, is where the picture gets more nuanced. Two peer-reviewed studies reached somewhat different conclusions, and both are worth understanding.
A study published in Open Forum Infectious Diseases compared antibody responses in people who received COVID and flu vaccines on the same day versus different days. The researchers found that IgG1 antibody responses to SARS-CoV-2 spike protein were roughly 6.75-fold higher at peak and nearly 4.7-fold higher at six months in the co-administered group. The flu vaccine responses, meanwhile, were unaffected by whether the vaccines were given together or apart.3Open Forum Infectious Diseases. Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses That is a surprising result: the flu shot may have actually boosted the COVID immune response rather than competing with it.
The TACTIC randomized clinical trial, published in The Lancet Regional Health – Europe, found the opposite pattern. In that trial, the group receiving both vaccines simultaneously showed lower COVID antibody levels compared to the group that received only a COVID booster. The concurrent vaccination group did not meet the study’s pre-set threshold for non-inferiority, and their virus-neutralizing antibody levels were significantly lower against both Delta and Omicron variants.4The Lancet Regional Health – Europe. Immunogenicity and safety of concomitant administration of COVID-19 and influenza vaccines: the TACTIC randomized clinical trial
So which result should you trust? The differences likely stem from the specific vaccine products used, the timing of prior infections or vaccinations in each study population, and the particular antibody types being measured. What matters most for a practical decision is this: a comparative effectiveness study looking at real-world outcomes found that co-administered COVID and flu vaccines were associated with similar effectiveness against both COVID-related and influenza-related outcomes compared with giving the two vaccines on separate days.5JAMA Network Open. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine Whatever subtle differences in antibody levels exist in the lab, they do not seem to translate into meaningful differences in protection in everyday life.
Same Arm or Different Arms
If you have decided to get both vaccines in one visit, the next question most people ask is whether you should get them in the same arm or use one arm for each. The intuition might be that spacing the shots across both arms would give each vaccine its own territory to work with. Researchers have tested this directly, and the answer is straightforward: it does not matter much.
A study published in EBioMedicine compared antibody responses between people who received both vaccines in the same arm (ipsilateral) and those who got one in each arm (contralateral). The response to the flu vaccine was equivalent regardless of arm choice. The COVID response was slightly higher in the same-arm group, but the researchers could not rule out equivalence between the groups.6PubMed Central. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses A separate randomized trial published in JCI Insight reached a comparable conclusion: flu antibody levels did not differ between groups, and while there was a slightly higher fold-change in some SARS-CoV-2 neutralizing antibodies in the opposite-arm group, overall binding and neutralizing titers were not significantly different.7PubMed Central. Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
The practical difference is really about soreness. If you get both shots in one arm, that arm tends to be more tender. If you split them, you may end up with mild soreness in both arms. Some people prefer concentrating all the discomfort in their non-dominant arm; others would rather spread it out. Either approach produces essentially the same immune response, so let personal comfort be your guide.
Missed Opportunities and the Convenience Factor
Despite the evidence supporting co-administration, most people still do not get both vaccines on the same visit. A U.S. pharmacy dataset analysis found that only about one in five COVID or influenza vaccinations involved co-administration. Among people who ultimately received both vaccines but on separate days, the majority got the second shot within 30 days, which highlights a large number of missed opportunities where both could have been given at once.8PubMed. Patterns of co-administration and sequential administration of COVID-19 and influenza vaccinations
Why does this matter? Every extra visit is a chance for life to get in the way. Someone gets their flu shot at a pharmacy in October, plans to come back for the COVID vaccine next week, and then a busy stretch at work or a mild cold pushes it off indefinitely. Research on behavioral factors among older adults has found that building trust and clearly communicating the safety and convenience of co-administration are key to improving uptake.9PubMed. Behavioral and psychosocial factors associated with coadministration of COVID-19 and influenza vaccines among the elderly For many people, the barrier is not a specific medical concern but rather the assumption that getting two vaccines at once seems excessive or unusual, even though the childhood vaccination schedule routinely involves multiple shots per visit.
Co-administration has a public health multiplier effect beyond individual convenience. When vaccination coverage rises even modestly, the downstream benefits in terms of fewer hospitalizations, fewer sick days, and less strain on healthcare systems add up quickly. Making it standard practice to offer both vaccines at a single appointment is one of the lowest-effort interventions available for improving seasonal vaccine uptake.
Older Adults and High-Dose Flu Formulations
For people aged 65 and older, the co-administration question comes with an additional wrinkle. Older adults are often recommended to receive high-dose or adjuvanted influenza vaccines, which provoke a stronger immune response to compensate for the natural weakening of the immune system with age. Data from a large cohort of older U.S. adults show that the vast majority of those who co-administered COVID and flu vaccines received the high-dose influenza formulation.10PubMed Central. COVID-19 and influenza vaccine co-administration among older U.S. adults This is reassuring because it means the combination of a high-dose flu shot plus a COVID vaccine is already happening at scale in the population most vulnerable to both diseases, without safety signals emerging from surveillance.
Older adults also stand to gain the most from the convenience of a single visit. Mobility challenges, transportation barriers, and caregiver schedules all make every additional healthcare appointment a logistical hurdle. For this group, consolidating vaccination visits is not just about convenience; it can be the difference between getting vaccinated at all and falling through the cracks.
The Combination Vaccine Approach
If getting two separate shots feels inelegant, the vaccine industry agrees. Moderna’s mRNA-1083 is a single-injection combination vaccine designed to protect against both seasonal influenza and SARS-CoV-2. In a randomized clinical trial of adults aged 50 and older, mRNA-1083 produced immune responses that were noninferior to receiving the two vaccines separately for all tested influenza strains and for SARS-CoV-2. For several influenza strains, the combo vaccine actually triggered higher responses than the standard-dose flu shot given to those aged 50 to 64, and it outperformed the high-dose flu shot for three of four strains in people 65 and older.11PubMed Central. Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years A Randomized Clinical Trial
A second phase 3 trial conducted in Japan corroborated these results. In that study of more than 2,000 participants aged 50 and older, mRNA-1083 demonstrated noninferior immune responses against all evaluated influenza strains and SARS-CoV-2, with superiority for several strains in the overall study population. Immune responses remained above baseline through six months after vaccination. Most side effects were mild to moderate, and there were no cases of myocarditis, pericarditis, or serious adverse events linked to the vaccine.12PubMed. Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged ≥50 years in Japan
A single shot that covers both diseases would eliminate the co-administration question entirely, remove the same-arm-or-different-arms debate, and make it much easier to maintain high vaccination coverage during fall and winter campaigns. Whether and when such a product receives regulatory approval will depend on ongoing review, but the clinical data so far look promising for what could become a routine annual vaccination in the coming years.
Common Concerns That the Data Addresses
A few recurring worries deserve direct responses based on the available evidence:
- Immune overload: The idea that your immune system can only handle one vaccine at a time has no support in the research. Your immune system encounters thousands of foreign molecules daily. Two vaccines, each targeting a specific pathogen, represent a tiny fraction of that workload. Pediatric vaccination schedules have long demonstrated that multiple vaccines given simultaneously produce appropriate responses without overwhelming the immune system.
- Worse side effects: As noted in the surveillance data, the increase in side-effect reporting from co-administration is small and the types of side effects remain the same.1PubMed Central. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US You are not doubling your misery; at most, you may feel slightly more fatigued for a day or two compared with getting just one shot.
- Reduced effectiveness: Real-world effectiveness data show similar protection whether the vaccines are co-administered or given separately.5JAMA Network Open. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine While individual immunogenicity studies show mixed laboratory results, the clinical outcome data, which is what ultimately matters for your health, is reassuring.
- Needing a waiting period: There is no required waiting period between the two vaccines. Early in the COVID vaccine rollout, some guidelines suggested spacing COVID vaccines apart from other shots as a precautionary measure while data were still being gathered. That guidance was updated as evidence accumulated showing co-administration was safe.
When Spacing Vaccines Apart Might Still Make Sense
For most healthy adults, getting both vaccines at once is the practical choice. But a few situations could tip the balance toward separate visits. If you have had a severe allergic reaction to a vaccine in the past, your provider may want to monitor you for a longer observation period and prefer to isolate which vaccine triggered any reaction. Similarly, people who are immunocompromised may be on specific vaccination schedules coordinated with their treatment cycles, and their care team may prefer to control the timing of each vaccine independently.
There is also a minor argument for spacing if you are someone who reacts very strongly to vaccines and wants to avoid overlapping recovery periods. Getting the flu shot one week and the COVID shot the next means you only feel rough once at a time rather than potentially dealing with a more intense single episode. This is a personal preference, not a medical recommendation. The trade-off is the risk of not making it back for the second appointment.
Pregnant individuals present another consideration. Both COVID and flu vaccines are recommended during pregnancy, and co-administration has been used in practice. However, because pregnancy involves unique immunological dynamics and because vaccine side effects like fever are treated with more caution during pregnancy, some providers prefer to stagger the shots to make it easier to identify the source of any reaction. If you are pregnant, a conversation with your obstetrician about timing makes sense.
RSV Vaccines and the Expanding Menu
The question of what you can safely combine at one visit is expanding beyond COVID and flu. RSV (respiratory syncytial virus) vaccines for older adults became available recently, adding a third respiratory virus vaccine to the fall schedule. Early data on co-administering RSV vaccines with COVID and flu shots are still being gathered, and guidance is evolving. Some preliminary studies have suggested that combining an RSV vaccine with either COVID or flu vaccines may slightly blunt the immune response to one or more of the vaccines, which is why some providers currently recommend spacing the RSV shot from the other two by a couple of weeks.
This is an area where the science is actively catching up with the practical demand. As more data accumulate, expect the guidance to become more definitive. For now, the most settled question is the one in the title: COVID and flu together on the same day is well-supported. Adding RSV to the mix on the same visit is a different question with a less mature evidence base, and worth discussing with your provider if all three are on your list for the season.